Nuveen Asset Management’s Acrivon Therapeutics ACRV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$80.7K Sell
2024
Q3
$180K Buy
2024
Q2
$68.6K Hold
2024
Q1
$84.5K Hold
2023
Q4
$58.2K Hold
2023
Q3
$113K Hold
2023
Q2
$153K Buy